Prosight Management, LP
CIK:0001617201
Hedge Fund
$621M AUM
39 holdings
Dallas, TX, United States
ProSight Management, LP is a hedge fund based in Dallas, Texas, United States. Registered in Delaware and operating since at least 2014, it manages investment portfolios, primarily for institutional clients. The firm is small, with approximately 5 employees, all of whom are directly focused on investments.
Investment Strategy
ProSight Management, LP typically employs a fundamental, value-oriented long/short equity investment strategy, focusing on deep research and concentrated positions in both public and private companies. The firm seeks to generate significant risk-adjusted returns through active portfolio management and opportunistic investments, often in sectors such as healthcare and technology.
Top Buys
U
UNHUNITEDHEALTH GROUP INC+$34.3M
G
GLPGGALAPAGOS NV+$16.6M
A
ADCTADC THERAPEUTICS SA+$14.6M
F
FOLDAMICUS THERAPEUTICS INC+$8.7M
C
CRNXCRINETICS PHARMACEUTICALS IN+$8.6M
Top Sells
S
SDGRSCHRODINGER INC-$7.6M
I
ISRGINTUITIVE SURGICAL INC-$6.9M
A
ABCLABCELLERA BIOLOGICS INC-$6.3M
R
RCKTROCKET PHARMACEUTICALS INC-$6.0M
M
MIRMMIRUM PHARMACEUTICALS INC-$5.3M
Top Holdings
G
GLPGGALAPAGOS NV+12.1%$49.6M
U
UNHUNITEDHEALTH GROUP INC+8.4%$34.3M
M
MGTXMEIRAGTX HLDGS PLC+7.3%$29.9M
A
ADCTADC THERAPEUTICS SA+6.8%$28.1M
B
BBIOBRIDGEBIO PHARMA INC+5.0%$20.4M
Equity Positions (39)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
G GLPG | GALAPAGOS NV | 12.11% | $49.6M | 1,773,649 | $33.24 | $27.99 | +$16.6M |
U UNH | UNITEDHEALTH GROUP INC | 8.37% | $34.3M | 110,000 | $311.97 | $311.97 | +$34.3M |
M MGTX | MEIRAGTX HLDGS PLC | 7.29% | $29.9M | 4,587,423 | $6.80 | $6.52 | +$4.9M |
A ADCT | ADC THERAPEUTICS SA | 6.84% | $28.1M | 10,467,771 | $2.68 | $2.68 | +$14.6M |
B BBIO | BRIDGEBIO PHARMA INC | 4.98% | $20.4M | 472,687 | $27.86 | $43.18 | -$677.1K |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+67.5%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+14.3%
HOSPITAL & MEDICAL SERVICE PLANS
+8.4%
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
+3.5%
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
+2.8%